<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0002403"><a href="http://purl.obolibrary.org/obo/MONDO_0002403">MONDO:0002403</a></h3>
<p><strong>Label:</strong> synovium cancer</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0010434">MONDO:0010434</a> (synovial sarcoma (disease)),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_3273">Orphanet:3273</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300813">OMIM:300813</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0012570">HP:0012570</a> (Synovial sarcoma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0030448">HP:0030448</a> (Soft tissue sarcoma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0012570">HP:0012570</a> (Synovial sarcoma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0012570">HP:0012570</a> (Synovial sarcoma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0100242">HP:0100242</a> (Sarcoma) 53.87%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0011792">HP:0011792</a> (Neoplasm by histology) 42.68%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 35.66%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) and <a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) 34.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) 34.28%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0030448">HP:0030448</a> (Soft tissue sarcoma) 32.81%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100242">HP:0100242</a> (Sarcoma) 31.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011792">HP:0011792</a> (Neoplasm by histology) 29.47%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 27.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) 26.02%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 25.82%</li>
</ul>
</body>
</html>
